CN Patent

CN106236715A — 药品剂型及其使用

Assigned to Triastek Inc · Expires 2016-12-21 · 9y expired

What this patent protects

本公开提供了一种用于口服的稳定固体药品剂型。所述药品剂型包括基体，其在内部形成隔室；以及被容纳在所述隔室中的药物基质。所述药品剂型的设计可以实现药物基质中药物活性成分的可控释放。

USPTO Abstract

本公开提供了一种用于口服的稳定固体药品剂型。所述药品剂型包括基体，其在内部形成隔室；以及被容纳在所述隔室中的药物基质。所述药品剂型的设计可以实现药物基质中药物活性成分的可控释放。

Drugs covered by this patent

Patent Metadata

Patent number
CN106236715A
Jurisdiction
CN
Classification
—
Expires
2016-12-21
Drug substance claim
No
Drug product claim
No
Assignee
Triastek Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.